These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2204310)

  • 1. Necrotizing vasculitis at granulocyte-macrophage-colony-stimulating factor injection sites.
    Farmer KL; Kurzrock R; Gutterman JU; Duvic M
    Arch Dermatol; 1990 Sep; 126(9):1243-4. PubMed ID: 2204310
    [No Abstract]   [Full Text] [Related]  

  • 2. GM-CSF: intravenous versus subcutaneous treatment.
    Aglietta M; Monzeglio C; Piacibello W; Aprá F; Stacchini A; Sanavio F; Mossetti C; Stern AC; Gavosto F
    Leukemia; 1990 Jul; 4(7):523. PubMed ID: 2197516
    [No Abstract]   [Full Text] [Related]  

  • 3. Granulocyte-macrophage colony-stimulating factor and vasculitis.
    Dreicer R; Schiller JH; Carbone PP
    Ann Intern Med; 1989 Jul; 111(1):91-2. PubMed ID: 2660649
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical studies of granulocyte-macrophage colony stimulating factor.
    Gutterman J
    Semin Oncol; 1988 Oct; 15(5 Suppl 5):52-3. PubMed ID: 3057645
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of recombinant human granulocyte-macrophage colony-stimulating factor as treatment for aplastic anemia and agranulocytosis.
    Champlin RE; Nimer SD; Oette D; Golde DW
    Prog Clin Biol Res; 1990; 338():143-50. PubMed ID: 2189137
    [No Abstract]   [Full Text] [Related]  

  • 6. [GM-CSF: granulocyte and macrophage colony stimulating factor. A biologic agent with a great therapeutic potential in oncology].
    Cortes-Funes H
    Rev Clin Esp; 1990 Mar; 186(4):173-4. PubMed ID: 2195605
    [No Abstract]   [Full Text] [Related]  

  • 7. Correction of granulocytopenia in Felty's syndrome by granulocyte-macrophage colony-stimulating factor. Simultaneous induction of interleukin-6 release and flare-up of the arthritis.
    Hazenberg BP; Van Leeuwen MA; Van Rijswijk MH; Stern AC; Vellenga E
    Blood; 1989 Dec; 74(8):2769-70. PubMed ID: 2510837
    [No Abstract]   [Full Text] [Related]  

  • 8. Nursing care of AIDS patients participating in a Phase I/II trial of recombinant human granulocyte-macrophage colony stimulating factor.
    Lynch M; Yanes L; Todd K
    Oncol Nurs Forum; 1988; 15(4):463-9. PubMed ID: 3041383
    [No Abstract]   [Full Text] [Related]  

  • 9. GM-CSF in combination with cytotoxic chemotherapy in AML patients.
    Bettelheim P; Muhm M; Valent P; Geissler K; Andreeff M; Haimi J; Sillaber C; Hinterberger W; Vieder L; Schulz G
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():127-30. PubMed ID: 2202464
    [No Abstract]   [Full Text] [Related]  

  • 10. [GM-CSF: its clinical administration; the treatment of aplasia].
    Rossi Ferrini P; Grossi A; Santini V; Vannucchi AM
    Haematologica; 1989 Oct; 74(5 Suppl):489-500. PubMed ID: 2512231
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression.
    Antman KS; Griffin JD; Elias A; Socinski MA; Ryan L; Cannistra SA; Oette D; Whitley M; Frei E; Schnipper LE
    N Engl J Med; 1988 Sep; 319(10):593-8. PubMed ID: 3045544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte-macrophage colony-stimulating factor: a teaching program for staff and patients.
    Woolery-Antill M
    J Pediatr Oncol Nurs; 1990 Apr; 7(2):61. PubMed ID: 2194506
    [No Abstract]   [Full Text] [Related]  

  • 13. Recurrent spleen enlargement during cyclic granulocyte-macrophage colony-stimulating factor therapy for myelodysplastic syndrome.
    Delmer A; Karmochkine M; Cadiou M; Gerhartz H; Zittoun R
    Am J Hematol; 1990 May; 34(1):73-4. PubMed ID: 2183595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with recombinant human granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor.
    Morstyn G; Lieschke GJ; Sheridan W; Layton J; Cebon J; Fox RM
    Semin Hematol; 1989 Apr; 26(2 Suppl 2):9-13. PubMed ID: 2471275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AIDS file. GM-CSF may boost WBC counts.
    Conover AC
    Am J Nurs; 1990 Apr; 90(4):29. PubMed ID: 2181877
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy.
    Lieschke GJ; Maher D; Cebon J; O'Connor M; Green M; Sheridan W; Boyd A; Rallings M; Bonnem E; Metcalf D
    Ann Intern Med; 1989 Mar; 110(5):357-64. PubMed ID: 2644886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical role of granulocyte-macrophage colony-stimulating factor.
    Mitsuyasu RT; Golde DW
    Hematol Oncol Clin North Am; 1989 Sep; 3(3):411-25. PubMed ID: 2698875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects.
    Thompson JA; Lee DJ; Kidd P; Rubin E; Kaufmann J; Bonnem EM; Fefer A
    J Clin Oncol; 1989 May; 7(5):629-37. PubMed ID: 2651578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical applications of colony-stimulating factors.
    Groopman JE
    Semin Oncol; 1988 Dec; 15(6 Suppl 6):27-33. PubMed ID: 2462748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic growth factors: biology and clinical application.
    Gabrilove JL; Jakubowski A
    J Natl Cancer Inst Monogr; 1990; (10):73-7. PubMed ID: 1693284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.